BALA CYNWYD, Pa., July 3, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Brightpoint, Inc ("Brightpoint" or the "Company") (Nasdaq - CELL) relating to the proposed acquisition by Ingram Micro, Inc. ("Ingram").
Under the terms of the transaction, Brightpoint shareholders would receive only $9.00 in cash for each share of Brightpoint stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Brightpoint for not acting in the Company's shareholders' best interests in connection with the sale process to Ingram. The transaction may undervalue Brightpoint as Brightpoint stock traded at $11.99 per share on February 1, 2012 and an analyst has placed a $12.00 price target on the stock.
If you own shares of Brightpoint stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at firstname.lastname@example.org visiting http://brodsky-smith.com/443-cell-brightpoint-inc.html, or by calling toll free 877-LEGAL-90.
SOURCE Brodsky & Smith, LLC